2-(2-Ethyl-2h-tetrazol-5-yl)-ethylamine → 1-(6-Bromo-imidazo[1,2-a]pyridin-2-yl)-3-[2-(2-ethyl-2h-tetrazol-5-yl)-ethyl]-urea

Participants

Role	Name	HCID	Charge
Reactant	2-(2-Ethyl-2h-tetrazol-5-yl)-ethylamine	HCID 55285500	—
Reactant	1-(6-Bromo-imidazo[1,2-a]pyridin-2-yl)-3-[2-(2-isopropyl-2H-tetrazol-5-yl)-ethyl]-urea	HCID 59251873	—
Reactant	2-(2-isopropyl-2H-tetrazol-5-yl)-ethylamine hydrochloride	HCID 66986243	—
Product	1-(6-Bromo-imidazo[1,2-a]pyridin-2-yl)-3-[2-(2-ethyl-2h-tetrazol-5-yl)-ethyl]-urea	HCID 25174491	—

Reaction Steps

This compound is prepared analogously to Intermediate E1 (described in preparation of intermediates section) by replacing 2-(2-isopropyl-2H-tetrazol-5-yl)-ethylamine hydrochloride (Intermediate D1) with 2-(2-ethyl-2H-tetrazol-5-yl)-ethylamine (Intermediate D2).

Provenance & Evidence

DOI	10.6084/m9.figshare.5104873.v1
Patent number	US08053574B2
Source dataset	uspto-grants-2011_11
ORD ID	ord-3756083e3e7943c4b45912e910617685
Source note	uspto-grants-2011_11